BIND Biosciences Secures $1,400,000 Series C Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2371f5e4-c699-497f-a237-08fe98521b5a&Preview=1 -
Date
6/29/2010 -
Company Name
BIND Biosciences -
Mailing Address
64 Sidney Street Cambridge, MA 02139 -
Company Description
BIND Biosciences, Inc. is a venture backed biopharmaceutical company focused on engineering targeted therapeutics. BIND’s technology was developed by world class laboratories at MIT and Harvard. -
Website
http://www.bindbio.com -
Transaction Type
Venture Equity -
Transaction Amount
$1,400,000 -
Transaction Round
Series C -
Proceeds Purposes
The company plans to use some of the new funding to usher its first drug-loaded nanoparticle into a Phase I clinical study for treating solid tumors. -
M&A Terms
-
Venture Investor
Undisclosed
